An orally available PD-1/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapy
出版年份 2021 全文链接
标题
An orally available PD-1/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapy
作者
关键词
PD-1/PD-L1, Peptide optimization, Trimethyl chitosan, Oral drug delivery, Cancer immunotherapy
出版物
JOURNAL OF CONTROLLED RELEASE
Volume 334, Issue -, Pages 376-388
出版商
Elsevier BV
发表日期
2021-05-01
DOI
10.1016/j.jconrel.2021.04.036
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responses
- (2020) Wenjie Zhai et al. Acta Pharmaceutica Sinica B
- A Novel D Peptide Identified by Mirror‐image Phage Display Blocks TIGIT/PVR for Cancer Immunotherapy
- (2020) Xiuman Zhou et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Determination of Rufinamide in the Presence of 1-[(2,6-Difluorophenyl)Methyl]-1H-1,2,3-Triazole-4 Carboxylic Acid Using RP-HPLC and Derivative Ratio Methods as Stability Indicating Assays to Be Applied on Dosage Form
- (2020) Sonia T Hassib et al. JOURNAL OF AOAC INTERNATIONAL
- CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
- (2020) Hongfei Wang et al. Journal for ImmunoTherapy of Cancer
- PD-1-expressing B cells suppress CD4+ and CD8+ T cells via PD-1/PD-L1-dependent pathway
- (2019) Xufu Wang et al. MOLECULAR IMMUNOLOGY
- Excretion stereoselectivity of triticonazole in rat urine and faeces
- (2019) Jing Nie et al. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART B-PESTICIDES FOOD CONTAMINANTS AND AGRICULTURAL WASTES
- The design of high affinity human PD-1 mutants by using molecular dynamics simulations (MD)
- (2018) Jiangfeng Du et al. Cell Communication and Signaling
- N -trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N -trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer
- (2018) Guanyu Chen et al. JOURNAL OF CONTROLLED RELEASE
- Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy
- (2018) Kui Li et al. JOURNAL OF DRUG TARGETING
- PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
- (2018) Fatemeh K. Dermani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small molecules
- (2018) Jeffrey Yang et al. MEDICINAL RESEARCH REVIEWS
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-affinity human PD-L1 variants attenuate the suppression of T cell activation
- (2017) Zhaoduan Liang et al. Oncotarget
- A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activity
- (2016) Yan Luan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy
- (2016) Zhongyi Yan et al. Oncotarget
- Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor
- (2016) Qiao Li et al. Oncotarget
- Blocking of the PD-1/PD-L1 Interaction by aD-Peptide Antagonist for Cancer Immunotherapy
- (2015) Hao-Nan Chang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- PEPstrMOD: structure prediction of peptides containing natural, non-natural and modified residues
- (2015) Sandeep Singh et al. Biology Direct
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Oral Absorption Promoters: Opportunities, Issues, and Challenges
- (2015) Chetan Yewale et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin
- (2015) Peiwen Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Development and validation of a stability indicating isocratic HPLC method for gemcitabine with application to drug release from poly lactic-co-glycolic acid nanoparticles and enzymatic degradation studies
- (2015) Guanyu Chen et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
- (2015) Krzysztof M. Zak et al. STRUCTURE
- Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
- (2015) Kim C. Ohaegbulam et al. TRENDS IN MOLECULAR MEDICINE
- ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers
- (2014) B. G. Pierce et al. BIOINFORMATICS
- pH sensitive N-succinyl chitosan grafted polyacrylamide hydrogel for oral insulin delivery
- (2014) Piyasi Mukhopadhyay et al. CARBOHYDRATE POLYMERS
- Oral peptide and protein delivery: intestinal obstacles and commercial prospects
- (2014) Alice L Smart et al. Expert Opinion on Drug Delivery
- Therapeutic applications of hydrogels in oral drug delivery
- (2014) Lindsey A Sharpe et al. Expert Opinion on Drug Delivery
- Enhanced Oral Delivery of Curcumin from N-trimethyl Chitosan Surface-Modified Solid Lipid Nanoparticles: Pharmacokinetic and Brain Distribution Evaluations
- (2014) Prakash Ramalingam et al. PHARMACEUTICAL RESEARCH
- Cancer immunotherapy
- (2013) Thomas F Gajewski et al. CURRENT OPINION IN IMMUNOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- PD-1 as a potential target in cancer therapy
- (2013) David F. McDermott et al. Cancer Medicine
- Development of an isocratic HPLC method for catechin quantification and its application to formulation studies
- (2012) Danhui Li et al. FITOTERAPIA
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy
- (2012) Katarzyna Karwacz et al. OncoImmunology
- Targeting PD-1/PD-L1 interactions for cancer immunotherapy
- (2012) Laurence Zitvogel et al. OncoImmunology
- Enhanced transbuccal salmon calcitonin (sCT) delivery: Effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation
- (2011) Dong-Ho Oh et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Drug delivery applications for superporous hydrogels
- (2011) David J Mastropietro et al. Expert Opinion on Drug Delivery
- Accelerating Protein Docking in ZDOCK Using an Advanced 3D Convolution Library
- (2011) Brian G. Pierce et al. PLoS One
- Insulin-Loaded Nanoparticles Based on N-Trimethyl Chitosan: In Vitro (Caco-2 Model) and Ex Vivo (Excised Rat Jejunum, Duodenum, and Ileum) Evaluation of Penetration Enhancement Properties
- (2010) Giuseppina Sandri et al. AAPS PHARMSCITECH
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthetic therapeutic peptides: science and market
- (2009) Patrick Vlieghe et al. DRUG DISCOVERY TODAY
- PD-1 signaling in primary T cells
- (2009) James L. Riley IMMUNOLOGICAL REVIEWS
- Trimethyl chitosan and its applications in drug delivery
- (2009) V. K. Mourya et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
- (2008) D. Y.-w. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started